Donepezil hydrochloride (Aspen) for the indication symptomatic treatment of mild to moderately severe Alzheimer’s dementia

The WAR has drawn up a pharmacotherapeutic report for the medicine donepezil (hydrochloride) Aspen film-coated tablets. Its therapeutic value was determined via comparison with rivastigmin and galantamin.. They reached the following conclusions. - the therapeutic value of donepezil is equal to that of rivastigmin and galantamin for the symptomatic treatment of mild to moderately severe Alzheimer’s dementia.

This report is a summary of recommendations by the National Health Care Institute. The original text is in Dutch.